Format

Send to

Choose Destination
Curr Opin Hematol. 2017 Nov;24(6):558-564. doi: 10.1097/MOH.0000000000000373.

Is there a standard-of-care for transfusion therapy in thalassemia?

Author information

1
aItalian National Blood Centre, National Institute of Health, Rome bDepartment of Hematology and Transfusion Medicine, Carlo Poma Hospital, Mantua cCentro della Microcitemia, Anemie Congenite e Dismetabolismo del Ferro, Ospedale Galliera, Genoa, Italy.

Abstract

PURPOSE OF REVIEW:

Thalassemia is the most common form of inherited anemia, characterized by variable clinical phenotypes. The purpose of this review is to summarize the transfusion support in thalassemia patients and the management of transfusion-related iron overload.

RECENT FINDINGS:

The most recent evidence on transfusion strategy and iron chelation therapy in thalassemia arising from clinical trials as well as from recommendation guidelines are critically discussed.

SUMMARY:

Enhancements in the global care of thalassemia, resulting from the combination of an appropriate transfusion approach and iron chelation therapy, have produced a significant improvement in the quality of life and, finally, in the prognosis of patients affected by this inherited hematologic disorder.

PMID:
28719386
DOI:
10.1097/MOH.0000000000000373
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center